Home/Filings/4/0001062993-23-021595
4//SEC Filing

Derby Michael 4

Accession 0001062993-23-021595

CIK 0001811623other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 4:08 PM ET

Size

6.2 KB

Accession

0001062993-23-021595

Insider Transaction Report

Form 4
Period: 2023-11-27
Derby Michael
DirectorExecutive Chairman10% Owner
Transactions
  • Sale

    Common Stock

    2023-11-27$1.03/sh185$19025,650 total
Holdings
  • Common Stock

    (indirect: By LLC)
    431,574
Footnotes (4)
  • [F1]The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs.
  • [F2]The sale price represents the weighted average sale price of the shares sold ranging from $0.97 to $1.03 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
  • [F3]The reporting person is the managing partner of TardiMed Sciences, LLC and has sole voting and dispositive control over the shares of Common Stock held by the entity. The reporting person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
  • [F4]Reflects a 1-for-17 reverse stock split effective October 30, 2023.

Issuer

PaxMedica, Inc.

CIK 0001811623

Entity typeother

Related Parties

1
  • filerCIK 0001809613

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 4:08 PM ET
Size
6.2 KB